SYROS PHARMACEUTICALS, INC. Interest Expense Nonoperating
SYROS PHARMACEUTICALS, INC. reported Interest Expense Nonoperating of $1.31 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-10-31.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2024-10-31
- SYROS PHARMACEUTICALS, INC. interest expense nonoperating for the quarter ending 2024-09-30 was $1.31M, a 0.69% increase year-over-year.
- SYROS PHARMACEUTICALS, INC. interest expense nonoperating for the quarter ending 2023-09-30 was $1.30M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 9 month |
|---|---|---|
| 2024-09-30 | $1.31M 10-Q · filed 2024-10-31 | $4.00M 10-Q · filed 2024-10-31 |
| 2023-09-30 | $1.30M 10-Q · filed 2024-10-31 | $3.80M 10-Q · filed 2024-10-31 |